Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Galecto Inc (NASDAQ: GLTO)

 
GLTO Technical Analysis
4
As on 8th Oct 2025 GLTO STOCK Price closed @ 10.65 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.86 & Strong Buy for SHORT-TERM with Stoploss of 0.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GLTOSTOCK Price

Open 10.50 Change Price %
High 11.66 1 Day -7.27 -40.57
Low 9.88 1 Week 6.85 180.26
Close 10.65 1 Month 7.29 216.96
Volume 1958941 1 Year 9.91 1339.19
52 Week High 14.15 | 52 Week Low 0.46
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
ADAP 0.21 50.00%
WBA 11.98 0.50%
OPEN 8.49 -8.61%
AMD 235.56 11.37%
PLUG 3.65 -5.68%
NVDA 189.11 2.20%
LMDX 0.02 0.00%
PCSA 0.48 33.33%
BITF 4.00 15.27%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
XBIO 10.36 141.49%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
TBLT 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
AXAS 0.03 -70.00%
 
 
GLTO
Daily Charts		 GLTO
Intraday Charts		 Whats New @
Bazaartrend		 GLTO
Free Analysis
 
GLTO Important Levels Intraday
RESISTANCE14.08
RESISTANCE12.98
RESISTANCE12.30
RESISTANCE11.62
SUPPORT9.68
SUPPORT9.00
SUPPORT8.32
SUPPORT7.22
 
GLTO Forecast October 2025
Share
4th UP Forecast11.02
3rd UP Forecast10.9
2nd UP Forecast10.83
1st UP Forecast10.75
1st DOWN Forecast10.55
2nd DOWN Forecast10.47
3rd DOWN Forecast10.4
4th DOWN Forecast10.28
 
GLTO Weekly Forecast
4th UP Forecast11.07
3rd UP Forecast10.94
2nd UP Forecast10.85
1st UP Forecast10.77
1st DOWN Forecast10.53
2nd DOWN Forecast10.45
3rd DOWN Forecast10.36
4th DOWN Forecast10.23
 
GLTO Forecast2025
4th UP Forecast70.85
3rd UP Forecast51.54
2nd UP Forecast39.61
1st UP Forecast27.68
1st DOWN Forecast-6.38
2nd DOWN Forecast-18.31
3rd DOWN Forecast-30.24
4th DOWN Forecast-49.55
 
 
GLTO Other Details
Segment EQ
Market Capital 84606824.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GLTO Address
GLTO
 
GLTO Latest News
 
Your Comments and Response on Galecto Inc
 
GLTO Business Profile
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service